Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381599074> ?p ?o ?g. }
- W4381599074 abstract "The amino-acid composition of the immunoglobulin variable region has been observed to impact antibody pharmacokinetics (PK). Here, we sought to improve the PK of the broad HIV-1-neutralizing VRC01-class antibodies, VRC07-523LS and N6LS, by reducing the net positive charge in their variable domains. We used a structure-guided approach to generate a panel of antibody variants incorporating select Arg or Lys substituted to Asp, Gln, Glu, or Ser. The engineered variants exhibited reduced affinity to heparin, reduced polyreactivity, and improved PK in human FcRn-transgenic mice. One variant, VRC07-523LS.v34, with three charge substitutions, had an observed in vivo half-life and an estimated human half-life of 10.8 and 60 days, respectively (versus 5.4 and 38 days for VRC07-523LS) and retained functionality, neutralizing 92% of a 208-strain panel at a geometric mean IC80 <1 µg/mL. Another variant, N6LS.C49, with two charge substitutions, had an observed in vivo half-life and an estimated human half-life of 14.5 and 80 days (versus 9.0 and 44 days for N6LS) and neutralized ~80% of 208 strains at a geometric mean IC80 <1 µg/mL. Since Arg and Lys residues are prevalent in human antibodies, we propose substitution of select Arg or Lys with Asp, Gln, Glu, or Ser in the framework region as a general means to improve PK of therapeutic antibodies." @default.
- W4381599074 created "2023-06-23" @default.
- W4381599074 creator A5012251819 @default.
- W4381599074 creator A5012679913 @default.
- W4381599074 creator A5014752118 @default.
- W4381599074 creator A5018055017 @default.
- W4381599074 creator A5026415856 @default.
- W4381599074 creator A5043677118 @default.
- W4381599074 creator A5044304028 @default.
- W4381599074 creator A5051108938 @default.
- W4381599074 creator A5056331601 @default.
- W4381599074 creator A5060867169 @default.
- W4381599074 creator A5068158817 @default.
- W4381599074 creator A5070084798 @default.
- W4381599074 creator A5071657202 @default.
- W4381599074 creator A5073226093 @default.
- W4381599074 creator A5077876916 @default.
- W4381599074 creator A5085482528 @default.
- W4381599074 creator A5085707997 @default.
- W4381599074 creator A5087833005 @default.
- W4381599074 creator A5089740833 @default.
- W4381599074 date "2023-06-21" @default.
- W4381599074 modified "2023-09-26" @default.
- W4381599074 title "Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain" @default.
- W4381599074 cites W1580407891 @default.
- W4381599074 cites W1855086894 @default.
- W4381599074 cites W1855237549 @default.
- W4381599074 cites W1955791284 @default.
- W4381599074 cites W1977937625 @default.
- W4381599074 cites W1978679376 @default.
- W4381599074 cites W1979162895 @default.
- W4381599074 cites W1991001030 @default.
- W4381599074 cites W1996045402 @default.
- W4381599074 cites W1996423252 @default.
- W4381599074 cites W2010409477 @default.
- W4381599074 cites W2011226881 @default.
- W4381599074 cites W2034501477 @default.
- W4381599074 cites W2035503835 @default.
- W4381599074 cites W2057119574 @default.
- W4381599074 cites W2077977162 @default.
- W4381599074 cites W2078317394 @default.
- W4381599074 cites W2082208556 @default.
- W4381599074 cites W2086742633 @default.
- W4381599074 cites W2090321248 @default.
- W4381599074 cites W2093529351 @default.
- W4381599074 cites W2104198642 @default.
- W4381599074 cites W2104446771 @default.
- W4381599074 cites W2108348023 @default.
- W4381599074 cites W2108422942 @default.
- W4381599074 cites W2113261643 @default.
- W4381599074 cites W2126075421 @default.
- W4381599074 cites W2130611069 @default.
- W4381599074 cites W2135151522 @default.
- W4381599074 cites W2138906847 @default.
- W4381599074 cites W2141666704 @default.
- W4381599074 cites W2169829977 @default.
- W4381599074 cites W2509135402 @default.
- W4381599074 cites W2515869346 @default.
- W4381599074 cites W2551273870 @default.
- W4381599074 cites W2570172057 @default.
- W4381599074 cites W2763435948 @default.
- W4381599074 cites W2901174889 @default.
- W4381599074 cites W2912424385 @default.
- W4381599074 cites W2945631985 @default.
- W4381599074 cites W2951311588 @default.
- W4381599074 cites W2955800002 @default.
- W4381599074 cites W2962804212 @default.
- W4381599074 cites W2988983475 @default.
- W4381599074 cites W2990616783 @default.
- W4381599074 cites W2999958881 @default.
- W4381599074 cites W3049189737 @default.
- W4381599074 cites W3133679081 @default.
- W4381599074 cites W3138945586 @default.
- W4381599074 cites W3186296934 @default.
- W4381599074 cites W3209528298 @default.
- W4381599074 cites W4205117348 @default.
- W4381599074 cites W4239659366 @default.
- W4381599074 doi "https://doi.org/10.1080/19420862.2023.2223350" @default.
- W4381599074 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37345226" @default.
- W4381599074 hasPublicationYear "2023" @default.
- W4381599074 type Work @default.
- W4381599074 citedByCount "1" @default.
- W4381599074 countsByYear W43815990742023 @default.
- W4381599074 crossrefType "journal-article" @default.
- W4381599074 hasAuthorship W4381599074A5012251819 @default.
- W4381599074 hasAuthorship W4381599074A5012679913 @default.
- W4381599074 hasAuthorship W4381599074A5014752118 @default.
- W4381599074 hasAuthorship W4381599074A5018055017 @default.
- W4381599074 hasAuthorship W4381599074A5026415856 @default.
- W4381599074 hasAuthorship W4381599074A5043677118 @default.
- W4381599074 hasAuthorship W4381599074A5044304028 @default.
- W4381599074 hasAuthorship W4381599074A5051108938 @default.
- W4381599074 hasAuthorship W4381599074A5056331601 @default.
- W4381599074 hasAuthorship W4381599074A5060867169 @default.
- W4381599074 hasAuthorship W4381599074A5068158817 @default.
- W4381599074 hasAuthorship W4381599074A5070084798 @default.
- W4381599074 hasAuthorship W4381599074A5071657202 @default.
- W4381599074 hasAuthorship W4381599074A5073226093 @default.
- W4381599074 hasAuthorship W4381599074A5077876916 @default.
- W4381599074 hasAuthorship W4381599074A5085482528 @default.